130 related articles for article (PubMed ID: 1533201)
1. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion.
Badalamenti S; Borroni G; Lorenzano E; Incerti P; Salerno F
Hepatology; 1992 May; 15(5):824-9. PubMed ID: 1533201
[TBL] [Abstract][Full Text] [Related]
2. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J
Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
[TBL] [Abstract][Full Text] [Related]
3. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
[TBL] [Abstract][Full Text] [Related]
4. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.
Morali GA; Tobe SW; Skorecki KL; Blendis LM
Hepatology; 1992 Jul; 16(1):42-8. PubMed ID: 1535608
[TBL] [Abstract][Full Text] [Related]
5. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
7. Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis.
Beutler JJ; Koomans HA; Rabelink TJ; Gaillard CA; Van Hattum J; Boer P; Dorhout Mees EJ
Hepatology; 1989 Aug; 10(2):148-53. PubMed ID: 2526072
[TBL] [Abstract][Full Text] [Related]
8. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
[TBL] [Abstract][Full Text] [Related]
9. Renal mechanisms of human alpha-atrial natriuretic peptide in man.
Brown J; Corr L
J Physiol; 1987 Jun; 387():31-46. PubMed ID: 2958623
[TBL] [Abstract][Full Text] [Related]
10. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
[TBL] [Abstract][Full Text] [Related]
11. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
Biollaz J; Nussberger J; Porchet M; Brunner-Ferber F; Otterbein ES; Gomez H; Waeber B; Brunner HR
Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
[TBL] [Abstract][Full Text] [Related]
12. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
13. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
[TBL] [Abstract][Full Text] [Related]
14. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis.
Salerno F; Badalamenti S; Incerti P; Capozza L; Mainardi L
Hepatology; 1988; 8(1):21-6. PubMed ID: 2962923
[TBL] [Abstract][Full Text] [Related]
15. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM
Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
[TBL] [Abstract][Full Text] [Related]
16. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
17. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
[TBL] [Abstract][Full Text] [Related]
18. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor inhibits the hypertension induced by chronic infusion of norepinephrine in conscious rats.
Yasujima M; Abe K; Kohzuki M; Tanno M; Kasai Y; Sato M; Omata K; Kudo K; Tsunoda K; Takeuchi K
Circ Res; 1985 Sep; 57(3):470-4. PubMed ID: 3161659
[TBL] [Abstract][Full Text] [Related]
20. Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining.
Bernardi M; Trevisani F; Fornalè L; Di Marco C; Gasbarrini A; Baraldini M; Ligabue A; Gasbarrini G
J Hepatol; 1994 Dec; 21(6):1116-22. PubMed ID: 7699237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
